XERIS BIOPHARMA HOLDINGS INC
XERSNASDAQ🏆 #1893 by market capEarnings Nov 5US Equity
$8.39▲ $0.42 (+5.01%)
Market closed · at close1h—
24h▲ 5.0%
7d▲ 3.3%
14d▲ 0.1%
30d▲ 2.9%
1y▲ 15.2%
🏦Market Cap
$1.45B
Small Cap
📈Revenue Growth (YoY)
+41.5%
High Growth
📊Gross Margin
85.9%
High
💵FCF Margin
15.1%
Healthy
⚖️P/S Ratio
4.4x
Fair
Otter Score
55
Weak
📊
Analyst Ratings
Price
$8.39
Total
10
Raised
0
Lowered
0
Avg PT
$8.82
H / L
$18 / $4
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-03-02 |
Piper Sandler | Reiterated | Neutral | 2025-11-07 |
Oppenheimer | Reiterated | Outperform | 2025-11-07 |
Leerink Partners | Reiterated | Outperform | 2025-08-19 |
Craig-Hallum | Reiterated | Buy | 2025-08-08 |
Jefferies | Reiterated | Buy | 2025-01-29 |
SVB Leerink | Reiterated | Outperform | 2023-01-27 |
Mizuho | Reiterated | Buy | 2022-03-16 |
Leerink Swann | Reiterated | Outperform | 2018-07-16 |
RBC Capital | Reiterated | Outperform | 2018-07-16 |
One row per institution, most recent rating